Development of a new HISCL automated CXCL9 immunoassay

C–X–C motif chemokine ligand 9 (CXCL9), a candidate biomarker, reflects type 1 (T1) inflammation pathology. Here, we report the analytical performance and clinical characteristics of a new CXCL9 reagent for a fully automated immunoassay device. We evaluated the limits of blank, detection, and quanti...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Takehiro, Yoshida, Maho, Watanabe, Shunsuke, Kondo, Takami, Asada, Hideo, Nakagawa, Atsushi, Tomii, Keisuke, Kameda, Masami, Otsuka, Mitsuo, Kuronuma, Koji, Chiba, Hirofumi, Katayanagi, Shinji, Miyazaki, Yasunari, Mori, Akio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066986/
https://www.ncbi.nlm.nih.gov/pubmed/37005469
http://dx.doi.org/10.1038/s41598-023-32513-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10066986/
https://www.ncbi.nlm.nih.gov/pubmed/37005469
http://dx.doi.org/10.1038/s41598-023-32513-8

Ejemplares similares